News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Adam S. Feldman, MD, MPH

Articles by Adam S. Feldman, MD, MPH

POINT: Is Immediate Radical Cystectomy Justified When Non–Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?

ByAdam S. Feldman, MD, MPH

June 15th 2016

After a thorough repeat TURBT, disease control can be achieved with intravesical BCG and a bladder-sparing approach.

Latest Updated Articles

POINT: Is Immediate Radical Cystectomy Justified When Non–Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?
Published: June 15th 2016 | Updated:

Trending on CancerNetwork

FDA Grants Fast Track Designation to Novel Imaging Agent in Clear Cell RCC

Evaluating the EVA1 Membrane Protein as a Target for Glioblastoma Therapy

Zanidatamab-Based Regimens Exhibit Improved PFS in Gastroesophageal Cancers

What is the Current State of ADC Treatment in EGFR-Amplified Glioblastoma?

How Can Chlorotoxin-Directed CAR T-Cell Therapy Impact Glioblastoma Care?

© 2025 MJH Life Sciences^®

All rights reserved.